Your session is about to expire
← Back to Search
Supported HBPM Program for High Blood Pressure (MonitorBP Trial)
N/A
Recruiting
Led By Ian Kronish, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-85 years old
Hypertension (as per International Statistical Classification of Diseases and Related Health Problems (ICD)-10 codes)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
MonitorBP Trial Summary
This trial looks at using navigator support and wireless home BP monitors to increase use of a home BP monitoring program in diverse patient populations.
Who is the study for?
This trial is for adults aged 18-85 with high blood pressure who are patients at certain New York medical practices, including those specializing in HIV medicine. They must have had a primary care visit within a specific timeframe and cannot participate if they have advanced dementia, frailty, pregnancy, stage 5 kidney disease, terminal illness or if their medical director opts out.Check my eligibility
What is being tested?
The study is testing whether a supported home blood pressure monitoring (HBPM) program combined with an implementation strategy can improve its adoption across diverse patient populations in multiple practices compared to usual care without the HBPM program.See study design
What are the potential side effects?
Since this trial involves implementing a home monitoring program rather than medication or invasive procedures, there are no direct side effects associated with the interventions being studied.
MonitorBP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 85 years old.
Select...
I have been diagnosed with high blood pressure.
MonitorBP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in patient's office systolic blood pressure (SBP)
Secondary outcome measures
Antihypertensive medication adherence
Change in patient's antihypertensive medication regimen intensity
Office diastolic blood pressure (DBP)
+1 moreMonitorBP Trial Design
4Treatment groups
Experimental Treatment
Group I: Intervention Clinics, Pre-Implementation PeriodExperimental Treatment1 Intervention
Usual care
Group II: Intervention Clinics, Post-Implementation PeriodExperimental Treatment1 Intervention
Access to Supported HBPM program plus a multifaceted implementation strategy designed to increase uptake of the program by primary care patients with uncontrolled hypertension
Group III: Control Clinics, Pre-Implementation PeriodExperimental Treatment1 Intervention
Usual care
Group IV: Control Clinics, Post-Implementation PeriodExperimental Treatment1 Intervention
Usual care
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityOTHER
1,055 Previous Clinical Trials
1,300,295 Total Patients Enrolled
New York Presbyterian HospitalOTHER
74 Previous Clinical Trials
33,220 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,431,259 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 85 years old.You must receive your primary care from specific healthcare networks in New York. This includes clinics that focus on HIV treatment.My location is eligible for a home blood pressure monitoring program.You have a very serious illness and are receiving end-of-life care.My doctor has advised against joining this trial.You have severe memory problems or are very frail.You are pregnant during the time they are measuring things for the study.My condition is end-stage kidney disease.I have been diagnosed with high blood pressure.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Clinics, Pre-Implementation Period
- Group 2: Intervention Clinics, Post-Implementation Period
- Group 3: Control Clinics, Pre-Implementation Period
- Group 4: Control Clinics, Post-Implementation Period
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical trial open to participants of any age, or are there restrictions on enrollment?
"According to the study parameters, individuals aged 18 and up to 85 are eligible for this clinical trial."
Answered by AI
Would I be eligible to participate in this clinical trial?
"To be included in this clinical trial, the applicant must have a diagnosis of hypertension and between 18 to 85 years old. Currently, 16000 participants are being sought for this research effort."
Answered by AI
Are there any remaining openings for participants in this clinical experiment?
"According to clinicaltrials.gov, this medical trial is not actively seeking new participants at the moment. It was initially posted on August 1st 2023 and has been updated recently on May 23rd 2023. Unfortunately, there are no opportunities for enrolment here; though 740 other active trials exist which may suit your needs."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger